The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
ThreeD Capital Inc. has announced significant shifts in its investment portfolio, involving both a strategic divestment and a new acquisition. The venture capital firm disposed of 977,000 common shares of Avicanna Inc. (AVCN), reducing its stake in the biopharmaceutical company. Simultaneously, ThreeD Capital strengthened its position in AI/ML Innovations Inc. (AIML) by acquiring a $450,000 convertible debenture through a private placement. These transactions resulted in ownership changes exceeding 2% for both entities, necessitating the filing of early warning reports under regulatory requirements. The moves align with the firm's strategy of opportunistic investment in disruptive technologies and junior resources. This portfolio rebalancing highlights ThreeD Capital's active management approach within the micro-cap sector.
Sign up free to access this content
Create Free Account